131 related articles for article (PubMed ID: 12131469)
1. Delayed visual loss following pergolide treatment of a prolactinoma.
Chuman H; Cornblath WT; Trobe JD; Gebarski SS
J Neuroophthalmol; 2002 Jun; 22(2):102-6. PubMed ID: 12131469
[TBL] [Abstract][Full Text] [Related]
2. Brain and optic chiasmal herniation following cabergoline treatment for a giant prolactinoma: wait or intervene?
Papanastasiou L; Fountoulakis S; Pappa T; Liberopoulos K; Malliopoulos D; Markou A; Piaditis G
Hormones (Athens); 2014; 13(2):290-5. PubMed ID: 24776630
[TBL] [Abstract][Full Text] [Related]
3. Her vision was tied down.
Dorotheo EU; Tang RA; Bahrani HM; Schiffman JS; Bhatti MT; Lewis SB
Surv Ophthalmol; 2005; 50(6):588-97. PubMed ID: 16263371
[TBL] [Abstract][Full Text] [Related]
4. Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma.
Raverot G; Jacob M; Jouanneau E; Delemer B; Vighetto A; Pugeat M; Borson-Chazot F
Clin Endocrinol (Oxf); 2009 Apr; 70(4):588-92. PubMed ID: 18673461
[TBL] [Abstract][Full Text] [Related]
5. Optic chiasmal herniation--an under recognized complication of dopamine agonist therapy for macroprolactinoma.
Jones SE; James RA; Hall K; Kendall-Taylor P
Clin Endocrinol (Oxf); 2000 Oct; 53(4):529-34. PubMed ID: 11012580
[TBL] [Abstract][Full Text] [Related]
6. Pergolide as primary therapy for macroprolactinomas.
Orrego JJ; Chandler WF; Barkan AL
Pituitary; 2000 Dec; 3(4):251-6. PubMed ID: 11788013
[TBL] [Abstract][Full Text] [Related]
7. Chiasmal herniation as a complication of bromocriptine therapy.
Taxel P; Waitzman DM; Harrington JF; Fagan RH; Rothfield NF; Chen HH; Malchoff CD
J Neuroophthalmol; 1996 Dec; 16(4):252-7. PubMed ID: 8956160
[TBL] [Abstract][Full Text] [Related]
8. Endonasal endoscopic transsphenoidal chiasmapexy using a clival cranial base cranioplasty for visual loss from massive empty sella following macroprolactinoma treatment with bromocriptine: case report.
Alvarez Berastegui GR; Raza SM; Anand VK; Schwartz TH
J Neurosurg; 2016 Apr; 124(4):1025-31. PubMed ID: 26339851
[TBL] [Abstract][Full Text] [Related]
9. Transnasal Transsphenoidal Elevation of Optic Chiasm in Secondary Empty Sella Syndrome Following Prolactinoma Treatment.
Cobb MIH; Crowson M; Mintz-Cole R; Husain AM; Berger M; Jang D; Codd P
World Neurosurg; 2018 Apr; 112():250-253. PubMed ID: 29421446
[TBL] [Abstract][Full Text] [Related]
10. Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma.
Dhanwal DK; Sharma AK
Pituitary; 2011 Dec; 14(4):384-7. PubMed ID: 19381817
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and drug therapy of prolactinoma.
Ciccarelli E; Camanni F
Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
[TBL] [Abstract][Full Text] [Related]
12. A case with prolactinoma treated with pergolide and its histology.
Kamada Y; Nakajima H; Saitoh Y; Yamamoto K; Kawarada Y; Arita N; Miyagawa J; Namba M; Hanafusa T; Sugiyama T; Hayakawa T; Matsuzawa Y
Endocr J; 1998 Aug; 45(4):605-6. PubMed ID: 9881915
[No Abstract] [Full Text] [Related]
13. Blurred vision during airline flight reveals prolactinoma.
Bodack MI
Optometry; 2003 Mar; 74(3):159-72. PubMed ID: 12645849
[TBL] [Abstract][Full Text] [Related]
14. Untethering of herniated left optic nerve after dopamine agonist treatment for giant prolactinoma.
Gkekas N; Primikiris P; Georgakoulias N
Acta Neurochir (Wien); 2013 Mar; 155(3):495-6. PubMed ID: 23314935
[No Abstract] [Full Text] [Related]
15. Long-term treatment of prolactin-secreting macroadenomas with pergolide.
Freda PU; Andreadis CI; Khandji AG; Khoury M; Bruce JN; Jacobs TP; Wardlaw SL
J Clin Endocrinol Metab; 2000 Jan; 85(1):8-13. PubMed ID: 10634356
[No Abstract] [Full Text] [Related]
16. Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report.
Koguchi M; Nakahara Y; Ebashi R; Ogata A; Shimokawa S; Masuoka J; Abe T
J Med Case Rep; 2019 Jan; 13(1):18. PubMed ID: 30660191
[TBL] [Abstract][Full Text] [Related]
17. [Simultaneous defect of visual fields and loss of libido--a coincidence?].
Jenni S; Seiler R; Christ ER; Stettler C
Praxis (Bern 1994); 2006 Dec; 95(49):1925-30. PubMed ID: 17212311
[TBL] [Abstract][Full Text] [Related]
18. Endonasal Chiasmapexy Using Autologous Cartilage/Bone for Empty Sella Syndrome After Cabergoline Therapy for Prolactinoma.
Ishihara E; Toda M; Sasao R; Ozawa H; Saito S; Ogawa K; Yoshida K
World Neurosurg; 2019 Jan; 121():145-148. PubMed ID: 30315973
[TBL] [Abstract][Full Text] [Related]
19. Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: a retrospective study.
Höfle G; Gasser R; Mohsenipour I; Finkenstedt G
Exp Clin Endocrinol Diabetes; 1998; 106(3):211-6. PubMed ID: 9710362
[TBL] [Abstract][Full Text] [Related]
20. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
Hamilton DK; Vance ML; Boulos PT; Laws ER
Pituitary; 2005; 8(1):53-60. PubMed ID: 16411069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
